Product NDC: | 47335-276 |
Proprietary Name: | Sumatriptan Succinate |
Non Proprietary Name: | Sumatriptan Succinate |
Active Ingredient(s): | 6 mg/.5mL & nbsp; Sumatriptan Succinate |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47335-276 |
Labeler Name: | Sun Pharma Global FZE |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090358 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110622 |
Package NDC: | 47335-276-40 |
Package Description: | 1 SYRINGE in 1 PACKAGE (47335-276-40) > .5 mL in 1 SYRINGE |
NDC Code | 47335-276-40 |
Proprietary Name | Sumatriptan Succinate |
Package Description | 1 SYRINGE in 1 PACKAGE (47335-276-40) > .5 mL in 1 SYRINGE |
Product NDC | 47335-276 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Sumatriptan Succinate |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20110622 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharma Global FZE |
Substance Name | SUMATRIPTAN SUCCINATE |
Strength Number | 6 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |